The EU will fund the effort through 2026, but the Cypriot government will contribute an additional €15 million over the next 15 years.
The project will provide approved researchers with access to samples and deidentified data collected from volunteer patients with Duchenne muscular dystrophy.
By participating in the project, the company, located in Tokyo, hopes to improve its cloud-based data management services while winning over new customers.
The ongoing effort — called Your DNA, Your Say — based its results on responses from nearly 9,000 people from the US, UK, Canada, and Australia.
As part of the shift, DNA.Land, which was run as an academic research project, will delete all data by the end of the month and ask customers to resubmit it.
The firm plans to address the fact that only 2 percent of human DNA samples used in pharmaceutical research are from Africans or those of African ancestry.
The acquisition will result in a new DLS division called HudsonAlpha Discovery that will provide a range of services to the pharma, biotech, and diagnostics industries.
The project dovetails with a separate effort to sequence the whole exomes of the samples, the first 50,000 of which became available to researchers this month.
The government has also pledged €5 million from the European Regional Development Fund to support the integration of genetic data into routine medical care.
The center, set to open next year, will establish a national sequencing infrastructure, manage a national genome database, and make the data available for research.
The US Department of Justice has proposed a rule change to enable DNA to be collected from migrants, the Associated Press reports.
Bernard Fisher, a surgeon who changed how breast cancer is treated, has died at 101, the New York Times reports.
A Washington Post columnist writes that she is skeptical about DNA-based diets.
In PNAS this week: recurrent inactivation of DEPDC5 in gastrointestinal stromal tumors, taxonomic reliability of GenBank sequences, and more.